Eplerenone crystalline form
A novel crystalline form (Form L) of the aldosterone receptor antagonist drug eplerenone is provided having relatively high physical stability at normal temperatures of storage and use. Pharmaceutical compositions are also provided comprising Form L eplerenone, optionally accompanied by one or more...
Saved in:
Main Authors | , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
28.09.2005
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A novel crystalline form (Form L) of the aldosterone receptor antagonist drug eplerenone is provided having relatively high physical stability at normal temperatures of storage and use. Pharmaceutical compositions are also provided comprising Form L eplerenone, optionally accompanied by one or more other solid state forms of eplerenone, in a total unit dosage amount of eplerenone of about 10 to about 1000 mg, and further comprising one or more pharmaceutically acceptable excipients. Processes are provided for preparing Form L eplerenone and for preparing compositions comprising Form L eplerenone. A method for prophylaxis and/or treatment of an aldosterone-mediated condition or disorder is also provided, comprising administering to a subject a therapeutically effective amount of eplerenone, wherein at least a fraction of the eplerenone present is Form L eplerenone. |
---|---|
AbstractList | A novel crystalline form (Form L) of the aldosterone receptor antagonist drug eplerenone is provided having relatively high physical stability at normal temperatures of storage and use. Pharmaceutical compositions are also provided comprising Form L eplerenone, optionally accompanied by one or more other solid state forms of eplerenone, in a total unit dosage amount of eplerenone of about 10 to about 1000 mg, and further comprising one or more pharmaceutically acceptable excipients. Processes are provided for preparing Form L eplerenone and for preparing compositions comprising Form L eplerenone. A method for prophylaxis and/or treatment of an aldosterone-mediated condition or disorder is also provided, comprising administering to a subject a therapeutically effective amount of eplerenone, wherein at least a fraction of the eplerenone present is Form L eplerenone. |
Author | BARTON, KATHLEEN P WIECZOREK, JOSEPH J MUDIPALLI, PARTHA S STAHL, GLENN L BORSCHARDT, THOMAS B GAUD, HENRY T DESAI, SUBHASH PIETZ, MARK A YAN, CHRIS Y CARLOS, MARLON V LITTLE, CLAY R FERRO, LEONARD J SING, YUEN-LUNG L GANSER, SCOTT |
Author_xml | – fullname: STAHL, GLENN L – fullname: LITTLE, CLAY R – fullname: BARTON, KATHLEEN P – fullname: FERRO, LEONARD J – fullname: WIECZOREK, JOSEPH J – fullname: CARLOS, MARLON V – fullname: DESAI, SUBHASH – fullname: BORSCHARDT, THOMAS B – fullname: YAN, CHRIS Y – fullname: MUDIPALLI, PARTHA S – fullname: SING, YUEN-LUNG L – fullname: GANSER, SCOTT – fullname: GAUD, HENRY T – fullname: PIETZ, MARK A |
BookMark | eNrjYmDJy89L5WSQdi3ISS1KBXEUkosqi0sSc3Iygey0_KJcHgbWtMSc4lReKM3NoODmGuLsoZtakB-fWlyQmJyal1oS7xpgaGphYGhp7GhkTIQSAB-5JQs |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | Kristalline Form von Eplerenon Form cristalline d'eplerenone |
Edition | 7 |
ExternalDocumentID | EP1580193A2 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_EP1580193A23 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 11:36:29 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French German |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_EP1580193A23 |
Notes | Application Number: EP20040030774 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050928&DB=EPODOC&CC=EP&NR=1580193A2 |
ParticipantIDs | epo_espacenet_EP1580193A2 |
PublicationCentury | 2000 |
PublicationDate | 20050928 |
PublicationDateYYYYMMDD | 2005-09-28 |
PublicationDate_xml | – month: 09 year: 2005 text: 20050928 day: 28 |
PublicationDecade | 2000 |
PublicationYear | 2005 |
RelatedCompanies | PHARMACIA CORPORATION |
RelatedCompanies_xml | – name: PHARMACIA CORPORATION |
Score | 2.6242328 |
Snippet | A novel crystalline form (Form L) of the aldosterone receptor antagonist drug eplerenone is provided having relatively high physical stability at normal... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES STEROIDS |
Title | Eplerenone crystalline form |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050928&DB=EPODOC&locale=&CC=EP&NR=1580193A2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQsUgxTrU0B-a0RMtUM10Tw1Rj3cQ0MwvdFIMUg9RksxTQPTWg1RZ-Zh6hJl4RphFMDJmwvTDgc0LLwYcjAnNUMjC_l4DL6wLEIJYLeG1lsX5SJlAo394txNZFDdY7BlZ_RhZqLk62rgH-Lv7Oas7OQJaaXxAwYwOLYktjR2BpzQpqRYOO2XcNcwJtSilArlHcBBnYAoCG5ZUIMTCl5gkzcDrDLl4TZuDwhc53A5nQrFcswiDtWpAD2pqXn5eqkFxUCWzUgU7TTlUANTpFGRTcXEOcPXSBtsTDfRTvGgB3j7EYAwtIqwSDgpmlUTLoMBXzxERjE2MDk0RTI8skc2NgMKeCbuM1k2SQxGmMFB45aQYu8IGjoLkUCxkGlpKi0lRZYFVakiQHDgQA9vt3JQ |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQsUgxTrU0B-a0RMtUM10Tw1Rj3cQ0MwvdFIMUg9RksxTQPTWg1RZ-Zh6hJl4RphFMDJmwvTDgc0LLwYcjAnNUMjC_l4DL6wLEIJYLeG1lsX5SJlAo394txNZFDdY7BlZ_RhZqLk62rgH-Lv7Oas7OQJaaXxAwYwOLYktjR2BpzWoOOpwX1HIKcwJtSilArlHcBBnYAoCG5ZUIMTCl5gkzcDrDLl4TZuDwhc53A5nQrFcswiDtWpAD2pqXn5eqkFxUCWzUgU7TTlUANTpFGRTcXEOcPXSBtsTDfRTvGgB3j7EYAwtIqwSDgpmlUTLoMBXzxERjE2MDk0RTI8skc2NgMKeCbuM1k2SQxGmMFB45eQZOjxBfn3gfTz9vaQYu8OGjoHkVCxkGlpKi0lRZYLVakiQHDhAAsL16Eg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Eplerenone+crystalline+form&rft.inventor=STAHL%2C+GLENN+L&rft.inventor=LITTLE%2C+CLAY+R&rft.inventor=BARTON%2C+KATHLEEN+P&rft.inventor=FERRO%2C+LEONARD+J&rft.inventor=WIECZOREK%2C+JOSEPH+J&rft.inventor=CARLOS%2C+MARLON+V&rft.inventor=DESAI%2C+SUBHASH&rft.inventor=BORSCHARDT%2C+THOMAS+B&rft.inventor=YAN%2C+CHRIS+Y&rft.inventor=MUDIPALLI%2C+PARTHA+S&rft.inventor=SING%2C+YUEN-LUNG+L&rft.inventor=GANSER%2C+SCOTT&rft.inventor=GAUD%2C+HENRY+T&rft.inventor=PIETZ%2C+MARK+A&rft.date=2005-09-28&rft.externalDBID=A2&rft.externalDocID=EP1580193A2 |